text:
Diabetes mellitus type 1
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Diabetes type 1
Synonyms
T1D, insulin-dependent diabetes,[1] juvenile diabetes[2]
A blue circle, the symbol for diabetes.[3]
Pronunciation
/daɪəbiːtiːs/
Specialty
Endocrinology
Symptoms
Frequent urination, increased thirst, increased hunger, weight loss[4]
Complications
Diabetic ketoacidosis, nonketotic hyperosmolar coma, poor healing, cardiovascular disease, damage to the eyes[4][5][2]
Usual onset
Relatively short period of time[1]
Causes
Not enough insulin[4]
Risk factors
Family history, celiac disease[5][6]
Diagnostic method
Blood sugar, A1C[5][7]
Prevention
Unknown[4]
Treatment
Insulin, diabetic diet, exercise[2][1]
Frequency
~7.5% of diabetes cases[8]
[edit on Wikidata]
Diabetes mellitus type 1 (also known as type 1 diabetes) is a form of diabetes mellitus in which not enough insulin is produced.[4] This results in high blood sugar levels in the body.[1] The classical symptoms are frequent urination, increased thirst, increased hunger, and weight loss.[4] Additional symptoms may include blurry vision, feeling tired, and poor healing.[2] Symptoms typically develop over a short period of time.[1]
The cause of type 1 diabetes is unknown.[4] However, it is believed to involve a combination of genetic and environmental factors.[1] Risk factors include having a family member with the condition.[5] The underlying mechanism involves an autoimmune destruction of the insulin-producing beta cells in the pancreas.[2] Diabetes is diagnosed by testing the level of sugar or A1C in the blood.[5][7] Type 1 diabetes can be distinguished from type 2 by testing for the presence of autoantibodies.[5]
There is no known way to prevent type 1 diabetes.[4] Treatment with insulin is required for survival.[1] Insulin therapy is usually given by injection just under the skin but can also be delivered by an insulin pump.[9] A diabetic diet and exercise are an important part of management.[2] Untreated, diabetes can cause many complications.[4] Complications of relatively rapid onset include diabetic ketoacidosis and nonketotic hyperosmolar coma.[5] Long-term complications include heart disease, stroke, kidney failure, foot ulcers and damage to the eyes.[4] Furthermore, complications may arise from low blood sugar caused by excessive dosing of insulin.[5]
Type 1 diabetes makes up an estimated 5–10% of all diabetes cases.[8] The number of people affected globally is unknown, although it is estimated that about 80,000 children develop the disease each year.[5] Within the United States the number of people affected is estimated at one to three million.[5][10] Rates of disease vary widely with approximately 1 new case per 100,000 per year in East Asia and Latin America and around 30 new cases per 100,000 per year in Scandinavia and Kuwait.[11][12] It typically begins in children and young adults.[1]
Play media
Video explanation of the various types of diabetes
Contents
[hide]
1 Signs and symptoms
2 Cause
2.1 Genetics
2.2 Environmental
2.2.1 Chemicals and drugs
3 Pathophysiology
4 Diagnosis
4.1 Autoantibodies
5 Prevention
5.1 Immunosuppressive drugs
5.2 Diet
6 Management
6.1 Lifestyle
6.2 Insulin
6.3 Pancreas transplantation
6.4 Islet cell transplantation
7 Complications
7.1 Urinary tract infection
7.2 Sexual dysfunction
7.2.1 Males
7.2.2 Females
8 Epidemiology
9 History
10 Society and culture
11 Research
11.1 Diet
11.1.1 Virus
11.2 Stem cells
11.3 Vaccine
12 References
13 External links
Signs and symptoms[edit]
Overview of the most significant symptoms of diabetes
A posterior subcapsular cataract is an uncommon symptom in those with type 1 DM[13]
The classical symptoms of type 1 diabetes include: polyuria (excessive urination), polydipsia (increased thirst), dry mouth, polyphagia (increased hunger), fatigue, and weight loss.[4]
Many type 1 diabetics are diagnosed when they present with diabetic ketoacidosis. The signs and symptoms of diabetic ketoacidosis include dry skin, rapid deep breathing, drowsiness, increased thirst, frequent urination, abdominal pain, and vomiting.[14]
About 12 percent of people with type 1 diabetes have clinical depression.[15]
About 6 percent of people with type 1 diabetes have celiac disease, but in most cases there are no digestive symptoms[16][6] or are mistakenly attributed to poor control of diabetes, gastroparesis or diabetic neuropathy.[16] In most cases, celiac disease is diagnosed after onset of type 1 diabetes. The association of celiac disease with type 1 diabetes increases the risk of complications, such as retinopathy and mortality. This association can be explained by shared genetic factors, and inflammation or nutritional deficiencies caused by untreated celiac disease, even if type 1 diabetes is diagnosed first.[6]
Some people with type 1 diabetes experience dramatic and recurrent swings in glucose levels, often occurring for no apparent reason; this is called "unstable diabetes" or "labile diabetes", and sometimes "brittle diabetes", although this term is no longer used.[17] The results of such swings can be irregular and unpredictable hyperglycemias, sometimes involving ketoacidosis, and sometimes serious hypoglycemias. Brittle diabetes occurs no more frequently than in 1% to 2% of diabetics.[17]
Cause[edit]
The cause of type 1 diabetes is unknown.[4] A number of explanatory theories have been put forward, and the cause may be one or more of the following: genetic susceptibility, a diabetogenic trigger, and exposure to an antigen.[18]
Genetics[edit]
Main article: Genetic causes of diabetes mellitus type 1
Type 1 diabetes is a disease that involves many genes. The risk of a child developing type 1 diabetes is about 5% if the father has it, about 8% if a sibling has it, and about 3% if the mother has it.[19] If one identical twin is affected there is about a 50% chance the other will also be affected.[20] Some studies of heritability has estimated it at 80 to 86%.[21][22]
More than 50 genes are associated with type 1 diabetes.[23] Depending on locus or combination of loci, they can be dominant, recessive, or somewhere in between. The strongest gene, IDDM1, is located in the MHC Class II region on chromosome 6, at staining region 6p21. Certain variants of this gene increase the risk for decreased histocompatibility characteristic of type 1. Such variants include DRB1 0401, DRB1 0402, DRB1 0405, DQA 0301, DQB1 0302 and DQB1 0201, which are common in North Americans of European ancestry and in Europeans.[24] Some variants also appear to be protective.[24]
Environmental[edit]
Environmental factors can influence expression of type 1. For identical twins, when one twin has type 1 diabetes, the other twin only has it 30%–50% of the time. Thus for 50%–70% of identical twins where one has the disease, the other will not, despite having exactly the same genome; this suggests that environmental factors, in addition to genetic factors, can influence the disease's prevalence.[25] Other indications of environmental influence include the presence of a 10-fold difference in occurrence among Caucasians living in different areas of Europe, and that people tend to acquire the rate of disease of their particular destination country.[18] Research is ongoing into the role of possible environmental triggers and protective factors, including dietary agents such as proteins in gluten,[26] time of weaning, gut microbiota[27] and viral infections.[28]
Chemicals and drugs[edit]
Some chemicals and drugs selectively destroy pancreatic cells. Pyrinuron (Vacor), a rodenticide introduced in the United States in 1976, selectively destroys pancreatic beta cells, resulting in type 1 diabetes after accidental poisoning.[29] Pyrinuron was withdrawn from the U.S. market in 1979 and it is not approved by the Environmental Protection Agency for use in the U.S.[30] Streptozotocin (Zanosar), an antineoplastic agent, is selectively toxic to the beta cells of the pancreatic islets. It is used in research for inducing type 1 diabetes on rodents[31] and for treating metastatic cancer of the pancreatic islet cells in patients whose cancer cannot be removed by surgery.[32] Other pancreatic problems, including trauma, pancreatitis, or tumors (either malignant or benign) can also lead to loss of insulin production.
Pathophysiology[edit]
The pathophysiology in diabetes type 1 is a destruction of beta cells in the pancreas, regardless of which risk factors or causative entities have been present.
Individual risk factors can have separate pathophysiological processes to, in turn, cause this beta cell destruction. Still, a process that appears to be common to most risk factors is an autoimmune response towards beta cells, involving an expansion of autoreactive CD4+ T helper cells and CD8+ T cells, autoantibody-producing B cells and activation of the innate immune system.[24][33]
After starting treatment with insulin a person's own insulin levels may temporarily improve.[34] This is believed to be due to altered immunity and is known as the "honeymoon phase".[34]
Diagnosis[edit]
See also: Glycated hemoglobin and Glucose tolerance test
WHO diabetes diagnostic criteria[35][36] edit
Condition
2 hour glucose
Fasting glucose
HbA1c
Unit mmol/l(mg/dl) mmol/l(mg/dl) mmol/mol DCCT %
Normal <7.8 (<140) <6.1 (<110) <42 <6.0
Impaired fasting glycaemia <7.8 (<140) ≥6.1(≥110) & <7.0(<126) 42-46 6.0–6.4
Impaired glucose tolerance ≥7.8 (≥140) <7.0 (<126) 42-46 6.0–6.4
Diabetes mellitus ≥11.1 (≥200) ≥7.0 (≥126) ≥48 ≥6.5
Diabetes mellitus is characterized by recurrent or persistent hyperglycemia, and is diagnosed by demonstrating any one of the following:[37]
Fasting plasma glucose level at or above 7.0 mmol/L (126 mg/dL).
Plasma glucose at or above 11.1 mmol/L (200 mg/dL) two hours after a 75 g oral glucose load as in a glucose tolerance test.
Symptoms of hyperglycemia and casual plasma glucose at or above 11.1 mmol/L (200 mg/dL).
Glycated hemoglobin (hemoglobin A1C) at or above 48 mmol/mol (≥ 6.5 DCCT %). (This criterion was recommended by the American Diabetes Association in 2010, although it has yet to be adopted by the WHO.)[38]
About a quarter of people with new type 1 diabetes have developed some degree of diabetic ketoacidosis (a type of metabolic acidosis which is caused by high concentrations of ketone bodies, formed by the breakdown of fatty acids and the deamination of amino acids) by the time the diabetes is recognized. The diagnosis of other types of diabetes is usually made in other ways. These include ordinary health screening, detection of hyperglycemia during other medical investigations, and secondary symptoms such as vision changes or unexplained fatigue. Diabetes is often detected when a person suffers a problem that may be caused by diabetes, such as a heart attack, stroke, neuropathy, poor wound healing or a foot ulcer, certain eye problems, certain fungal infections, or delivering a baby with macrosomia or hypoglycemia (low blood sugar).[citation needed]
A positive result, in the absence of unequivocal hyperglycemia, should be confirmed by a repeat of any of the above-listed methods on a different day. Most physicians prefer to measure a fasting glucose level because of the ease of measurement and the considerable time commitment of formal glucose tolerance testing, which takes two hours to complete and offers no prognostic advantage over the fasting test.[39] According to the current definition, two fasting glucose measurements above 126 mg/dL (7.0 mmol/L) is considered diagnostic for diabetes mellitus.[citation needed]
In type 1, pancreatic beta cells in the islets of Langerhans are destroyed, decreasing endogenous insulin production. This distinguishes type 1's origin from type 2. Type 2 diabetes is characterized by insulin resistance, while type 1 diabetes is characterized by insulin deficiency, generally without insulin resistance. Another hallmark of type 1 diabetes is islet autoreactivity, which is generally measured by the presence of autoantibodies directed towards the beta cells.[citation needed]
Autoantibodies[edit]
The appearance of diabetes-related autoantibodies has been shown to be able to predict the appearance of diabetes type 1 before any hyperglycemia arises, the main ones being islet cell autoantibodies, insulin autoantibodies, autoantibodies targeting the 65-kDa isoform of glutamic acid decarboxylase (GAD), autoantibodies targeting the phosphatase-related IA-2 molecule, and zinc transporter autoantibodies (ZnT8).[18] By definition, the diagnosis of diabetes type 1 can be made first at the appearance of clinical symptoms and/or signs, but the emergence of autoantibodies may itself be termed "latent autoimmune diabetes". Not everyone with autoantibodies progresses to diabetes type 1, but the risk increases with the number of antibody types, with three to four antibody types giving a risk of progressing to diabetes type 1 of 60%–100%.[18] The time interval from emergence of autoantibodies to clinically diagnosable diabetes can be a few months in infants and young children, but in some people it may take years – in some cases more than 10 years.[18] Islet cell autoantibodies are detected by conventional immunofluorescence, while the rest are measured with specific radiobinding assays.[18]
Prevention[edit]
Type 1 diabetes is not currently preventable.[40] Some researchers believe it might be prevented at the latent autoimmune stage, before it starts destroying beta cells.[24]
Immunosuppressive drugs[edit]
Cyclosporine A, an immunosuppressive agent, has apparently halted destruction of beta cells (on the basis of reduced insulin usage), but its kidney toxicity and other side effects make it highly inappropriate for long-term use.[24]
Anti-CD3 antibodies, including teplizumab and otelixizumab, had suggested evidence of preserving insulin production (as evidenced by sustained C-peptide production) in newly diagnosed type 1 diabetes patients.[24] A probable mechanism of this effect was believed to be preservation of regulatory T cells that suppress activation of the immune system and thereby maintain immune system homeostasis and tolerance to self-antigens.[24] The duration of the effect is still unknown, however.[24] In 2011, Phase III studies with otelixizumab and teplizumab both failed to show clinical efficacy, potentially due to an insufficient dosing schedule.[41][42]
An anti-CD20 antibody, rituximab, inhibits B cells and has been shown to provoke C-peptide responses three months after diagnosis of type 1 diabetes, but long-term effects of this have not been reported.[24]
Diet[edit]
Some research has suggested breastfeeding decreases the risk in later life[43][44] and early introduction of gluten-containing cereals in the diet increases the risk of developing islet cell autoantibodies;[45] various other nutritional risk factors are being studied, but no firm evidence has been found.[46] Giving children 2000 IU of vitamin D daily during their first year of life is associated with reduced risk of type 1 diabetes, though the causal relationship is obscure.[47]
Children with antibodies to beta cell proteins (i.e. at early stages of an immune reaction to them) but no overt diabetes, and treated with niacinamide (vitamin B3), had less than half the diabetes onset incidence in a seven-year time span than did the general population, and an even lower incidence relative to those with antibodies as above, but who received no niacinamide.[48]
People with type 1 diabetes and undiagnosed celiac disease have worse glycaemic control and a higher prevalence of nephropathy and retinopathy. Gluten-free diet, when performed strictly, improves diabetes symptoms and appears to have a protective effect against developing long-term complications. Nevertheless, dietary management of both these diseases is challenging and these patients have poor compliance of the diet.[49]
Management[edit]
Further information: Diabetes management
Diabetes is often managed by a number of health care providers including a dietitian, nurse educator, eye doctor, endocrinologist, and podiatrist.[50]
Lifestyle[edit]
A low-carbohydrate diet, exercise, and medications is useful in type 1 DM.[51] There are camps for children to teach them how and when to use or monitor their insulin without parental help.[52] As psychological stress may have a negative effect on diabetes, a number of measures have been recommended including: exercising, taking up a new hobby, or joining a charity among others.[53]
Insulin[edit]
Main article: Insulin therapy
Injections of insulin—either via subcutaneous injection or insulin pump— are necessary for those living with type 1 diabetes because it cannot be treated by diet and exercise alone.[54] Insulin dosage is adjusted taking into account food intake, blood glucose levels and physical activity.
Untreated type 1 diabetes can commonly lead to diabetic ketoacidosis which is a diabetic coma which can be fatal if untreated.[55] Diabetic ketoacidosis can cause cerebral edema (accumulation of liquid in the brain). This is a life-threatening issue and children are at a higher risk for cerebral edema than adults, causing ketoacidosis to be the most common cause of death in pediatric diabetes.[56]
Treatment of diabetes focuses on lowering blood sugar or glucose (BG) to the near normal range, approximately 80–140 mg/dl (4.4–7.8 mmol/L).[57] The ultimate goal of normalizing BG is to avoid long-term complications that affect the nervous system (e.g. peripheral neuropathy leading to pain and/or loss of feeling in the extremities), and the cardiovascular system (e.g. heart attacks, vision loss). This level of control over a prolonged period of time can be varied by a target HbA1c level of less than 7.5%.[5]
There are four main types of insulin: rapid acting insulin, short-acting insulin, intermediate-acting insulin, and long-acting insulin. The rapid acting insulin is used as a bolus dosage. The action onsets in 15 minutes with peak actions in 30 to 90 minutes. Short acting insulin action onsets within 30 minutes with the peak action around 2 to 4 hours. Intermediate acting insulin action onsets within one to two hours with peak action of four to 10 hours. Long-acting insulin is usually given once per day. The action onset is roughly 1 to 2 hours with a sustained action of up to 24 hours. Some insulins are biosynthetic products produced using genetic recombination techniques; formerly, cattle or pig insulins were used, and even sometimes insulin from fish.[58]
People with type 1 diabetes always need to use insulin, but treatment can lead to low BG (hypoglycemia), i.e. BG less than 70 mg/dl (3.9 mmol/l). Hypoglycemia is a very common occurrence in people with diabetes, usually the result of a mismatch in the balance among insulin, food and physical activity. Symptoms include excess sweating, excessive hunger, fainting, fatigue, lightheadedness and shakiness.[59] Mild cases are self-treated by eating or drinking something high in sugar. Severe cases can lead to unconsciousness and are treated with intravenous glucose or injections with glucagon. Continuous glucose monitors can alert patients to the presence of dangerously high or low blood sugar levels, but technical issues have limited the effect these devices have had on clinical practice.[citation needed]
As of 2016 an artificial pancreas looks promising with safety issues still being studied.[60]
Pancreas transplantation[edit]
Main article: Pancreas transplantation
In some cases, a pancreas transplant can restore proper glucose regulation. However, the surgery and accompanying immunosuppression required may be more dangerous than continued insulin replacement therapy, so is generally only used with or some time after a kidney transplant. One reason for this is that introducing a new kidney requires taking immunosuppressive drugs such as cyclosporine, which allows the introduction of a new pancreas to a person with diabetes without any additional immunosuppressive therapy. However, pancreas transplants alone may be beneficial in people with extremely labile type 1 diabetes mellitus.[61]
Islet cell transplantation[edit]
Main article: Islet cell transplantation
Islet cell transplantation may be an option for some people with type 1 diabetes that are not well controlled with insulin.[62] Difficulties include finding donors that are a compatible, getting the new islets to survive, and the side effects from the medications used to prevent rejection.[62] Success rates, defined as not needing insulin at 3 years follow the procedure occurred in 44% in on registry from 2010.[62]
Complications[edit]
Further information: Complications of diabetes mellitus
Complications of poorly managed type 1 diabetes mellitus may include cardiovascular disease, diabetic neuropathy, and diabetic retinopathy, among others. However, cardiovascular disease[63] as well as neuropathy[64] may have an autoimmune basis, as well. Women with type 1 DM have a 40% higher risk of death as compared to men with type 1 DM.[65] The life expectancy of an individual with type 1 diabetes is 11 years less for men and 13 years less for women.[66]
Urinary tract infection[edit]
People with diabetes show an increased rate of urinary tract infection.[67] The reason is bladder dysfunction that is more common in diabetics than in non-diabetics due to diabetic nephropathy. When present, nephropathy can cause a decrease in bladder sensation, which in turn, can cause increased residual urine, a risk factor for urinary tract infections.[68]
Sexual dysfunction[edit]
Sexual dysfunction in diabetics is often a result of physical factors such as nerve damage and/or poor circulation, and psychological factors such as stress and/or depression caused by the demands of the disease.[69][70]
Males[edit]
The most common sexual issues in diabetic males are problems with erections and ejaculation: "With diabetes, blood vessels supplying the penis’s erectile tissue can get hard and narrow, preventing the adequate blood supply needed for a firm erection. The nerve damage caused by poor blood glucose control can also cause ejaculate to go into the bladder instead of through the penis during ejaculation, called retrograde ejaculation. When this happens, semen leaves the body in the urine."[69] Another cause for erectile dysfunction are the reactive oxygen species created as a result of the disease. Antioxidants can be used to help combat this.[71]
Females[edit]
While there is less material on the correlation between diabetes and female sexual dysfunction than male sexual dysfunction, studies have shown there to be a significant prevalence of sexual problems in diabetic women.[70] Common problems include reduced sensation in the genitals, dryness, difficulty/inability to orgasm, pain during sex, and decreased libido.[69] In some cases diabetes has been shown to decrease oestrogen levels in females, which can affect vaginal lubrication.[70]
Oral contraceptives can be taken by diabetics. Sometimes, contraceptive pills can cause a blood sugar imbalance, but this usually can be corrected by a dosage change.[70] As with any medication, side effects should be taken into account and monitored to prevent serious complications with diabetes.[70]
Women with type 1 diabetes show a higher than normal rate of polycystic ovarian syndrome (PCOS).[72] The reason may be that the ovaries are exposed to high insulin concentrations since women with type 1 diabetes can have frequent hyperglycemia.[73]
Epidemiology[edit]
Type 1 diabetes makes up an estimated 5–10% of all diabetes cases[8] or 11–22 million worldwide.[40] In 2006 it affected 440,000 children under 14 years of age and was the primary cause of diabetes in those less than 10 years of age.[74] The incidence of type 1 diabetes has been increasing by about 3% per year.[74]
Rates vary widely by country. In Finland, the incidence is a high of 57 per 100,000 per year, in Japan and China a low of 1 to 3 per 100,000 per year, and in Northern Europe and the U.S., an intermediate of 8 to 17 per 100,000 per year.[75][76]
In the United States, type 1 diabetes affected about 208,000 youths under the age of 20 in 2015. Over 18,000 youths are diagnosed with Type 1 diabetes every year. Every year about 234,051 Americans die due to diabetes (type I or II) or diabetes-related complications, with 69,071 having it as the primary cause of death.[77]
History[edit]
Type 1 diabetes was described as an autoimmune disease in the 1970s, based on observations that autoantibodies against islets were discovered in diabetics with other autoimmune deficiencies.[78] It was also shown in the 1980s that immunosuppressive therapies could slow disease progression, further supporting the idea that type 1 diabetes is an autoimmune disorder.[79] The name juvenile diabetes was used earlier as it often first is diagnosed in childhood.
In Australia, approximately one million Australians have been diagnosed with type 1 diabetes and Australia ranks 7th-highest in the world with children under 14 years of age. Between 2000 and 2013, 31,895 new cases were established, with 2,323 in 2013, a rate of 10–13 cases per 100,00 people each year. Aboriginals and Torres Strait Islander people are less affected.[80][81]
Society and culture[edit]
See also: List of people with diabetes mellitus type 1
The disease was estimated to cause $10.5 billion in annual medical costs ($875 per month per diabetic) and an additional $4.4 billion in indirect costs ($366 per month per person with diabetes) in the U.S.[82] In the United States $245 billion every year is attributed to diabetes. Individuals diagnosed with diabetes have 2.3 times the health care costs as individuals who do not have diabetes. One in 10 health care dollars are spent on individuals with diabetes.[77]
Research[edit]
Funding for research into type 1 diabetes originates from government, industry (e.g., pharmaceutical companies), and charitable organizations. Government funding in the United States is distributed via the National Institute of Health, and in the UK via the National Institute for Health Research or the Medical Research Council. JDRF, founded by parents of children with type 1 diabetes, is the world's largest provider of charity based funding for type 1 diabetes research. Other charities include the American Diabetes Association, Diabetes UK, Diabetes Research and Wellness Foundation,[83] Diabetes Australia, the Canadian Diabetes Association.
A number of approaches have been explored to understand causes and provide treatments for type 1.
Diet[edit]
Data suggest that gliadin (a protein present in gluten) might play a role in the development of type 1 diabetes, but the mechanism is not fully understood.[26][45] Increased intestinal permeability caused by gluten and the subsequent loss of intestinal barrier function, which allows the passage of pro-inflammatory substances into the blood, may induce the autoimmune response in genetically predisposed individuals to type 1 diabetes.[6][45] There is evidence from experiments conducted in animal models that removal of gluten from the diet may prevent the onset type 1 diabetes[26][84] but there has been conflicting research in humans.[84]
Virus[edit]
One theory proposes that type 1 diabetes is a virus-triggered autoimmune response in which the immune system attacks virus-infected cells along with the beta cells in the pancreas.[28][85] Several viruses have been implicated, including enteroviruses (especially coxsackievirus B), cytomegalovirus, Epstein–Barr virus, mumps virus, rubella virus and rotavirus, but to date there is no stringent evidence to support this hypothesis in humans.[86] A 2011 systematic review and meta-analysis showed an association between enterovirus infections and type 1 diabetes, but other studies have shown that, rather than triggering an autoimmune process, enterovirus infections, as coxsackievirus B, could protect against onset and development of type 1 diabetes.[87]
Stem cells[edit]
Pluripotent stem cells can be used to generate beta cells but previously these cells did not function as well as normal beta cells.[88] In 2014 more mature beta cells were produced which released insulin in response to blood sugar when transplanted into mice.[89][90] Before these techniques can be used in humans more evidence of safety and effectiveness is needed.[88]
Vaccine[edit]
Vaccines to treat or prevent Type 1 diabetes are designed to induce immune tolerance to insulin or pancreatic beta cells.[91] While Phase II clinical trials of a vaccine containing alum and recombinant GAD65, an autoantigen involved in type 1 diabetes, were promising, as of 2014 Phase III had failed.[91] As of 2014, other approaches, such as a DNA vaccine encoding proinsulin and a peptide fragment of insulin, were in early clinical development.[91]
References[edit]
^ Jump up to: a b c d e f g h "Causes of Diabetes". NIDDK. August 2014. Archived from the original on 10 August 2016. Retrieved 31 July 2016.
^ Jump up to: a b c d e f "Types of Diabetes". NIDDK. February 2014. Archived from the original on 16 August 2016. Retrieved 31 July 2016.
Jump up ^ "Diabetes Blue Circle Symbol". International Diabetes Federation. 17 March 2006. Archived from the original on 5 August 2007.
^ Jump up to: a b c d e f g h i j k l "Diabetes Fact sheet N°312". WHO. November 2016. Archived from the original on 26 August 2013. Retrieved 29 May 2017.
^ Jump up to: a b c d e f g h i j k Chiang, J. L.; Kirkman, M. S.; Laffel, L. M. B.; Peters, A. L. (16 June 2014). "Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association". Diabetes Care. 37 (7): 2034–2054. doi:10.2337/dc14-1140. PMID 24935775.
^ Jump up to: a b c d Elfström P, Sundström J, Ludvigsson JF (2014). "Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes". Alimentary Pharmacology & Therapeutics. 40 (10): 1123–32. doi:10.1111/apt.12973. PMID 25270960. Archived from the original on 22 August 2016.
^ Jump up to: a b "Diagnosis of Diabetes and Prediabetes". NIDDK. May 2015. Archived from the original on 16 August 2016. Retrieved 31 July 2016.
^ Jump up to: a b c Daneman D (11 March 2006). "Type 1 diabetes". The Lancet. 367 (9513): 847–58. doi:10.1016/S0140-6736(06)68341-4. PMID 16530579.
Jump up ^ "Alternative Devices for Taking Insulin". NIDDK. July 2016. Archived from the original on 16 August 2016. Retrieved 31 July 2016.
Jump up ^ "FAST FACTS Data and Statistics about Diabetes". American Diabetes Association. Archived from the original on 16 December 2015. Retrieved 25 July 2014.
Jump up ^ Global report on diabetes (PDF). World Health Organization. 2016. pp. 26–27. ISBN 978-92-4-156525-7. Archived (PDF) from the original on 7 October 2016. Retrieved 31 July 2016.
Jump up ^ Skyler, Jay (2012). Atlas of diabetes (4th ed.). New York: Springer. pp. 67–68. ISBN 978-1-4614-1028-7. Archived from the original on 8 September 2017.
Jump up ^ Uspal, NG; Schapiro, ES (February 2011). "Cataracts as the initial manifestation of type 1 diabetes mellitus". Pediatric Emergency Care. 27 (2): 132–4. PMID 21293223.
Jump up ^ "webmd Symptoms Type I Diabetes". Archived from the original on 23 June 2013.
Jump up ^ Roy T, Lloyd CE (2012). "Epidemiology of depression and diabetes: a systematic review". Journal of Affective Disorders. 142 Suppl: S8–21. doi:10.1016/S0165-0327(12)70004-6. PMID 23062861.
^ Jump up to: a b See JA, Kaukinen K, Makharia GK, Gibson PR, Murray JA (Oct 2015). "Practical insights into gluten-free diets". Nature Reviews Gastroenterology & Hepatology (Review). 12 (10): 580–91. doi:10.1038/nrgastro.2015.156. PMID 26392070. Coeliac disease in T1DM is asymptomatic ...Clinical manifestations of coeliac disease, such as abdominal pain, gas, bloating, diarrhoea and weight loss can be present in patients with T1DM, but are often attributed to poor control of diabetes, gastroparesis or diabetic neuropathy
^ Jump up to: a b "Diabetes Mellitus (DM): Diabetes Mellitus and Disorders of Carbohydrate Metabolism: Merck Manual Professional". Merck.com. February 2017.
^ Jump up to: a b c d e f Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Akerblom HK (2005). "Environmental Triggers and Determinants of Type 1 Diabetes". Diabetes. 54: S125–S136. doi:10.2337/diabetes.54.suppl_2.S125. PMID 16306330.
Jump up ^ Pociot, F; Lernmark, Å (4 June 2016). "Genetic risk factors for type 1 diabetes". The Lancet. 387 (10035): 2331–9. doi:10.1016/s0140-6736(16)30582-7. PMID 27302272.
Jump up ^ Owen, Katharine (2014). Oxford Handbook of Endocrinology and Diabetes. Oxford University Press. p. 690. ISBN 9780199644438. Archived from the original on 8 September 2017.
Jump up ^ Narayan, K. M. Venkat; Williams, Desmond; Gregg, Edward W.; Cowie, Catherine C. (2010). Diabetes Public Health: From Data to Policy. Oxford University Press. p. 671. ISBN 9780199749140. Archived from the original on 8 September 2017.
Jump up ^ Melmed, Shlomo; Polonsky, Kenneth S.; Larsen, P. Reed; Kronenberg, Henry (2015). Williams Textbook of Endocrinology. Elsevier Health Sciences. p. 50. ISBN 9780323297387. Archived from the original on 8 September 2017.
Jump up ^ Ionescu-Tîrgovişte, Constantin; Gagniuc, Paul Aurelian; Guja, Cristian. "Structural Properties of Gene Promoters Highlight More than Two Phenotypes of Diabetes". PLOS One. 10 (9): e0137950. doi:10.1371/journal.pone.0137950. PMC 4574929  . PMID 26379145. Archived from the original on 17 November 2015.
^ Jump up to: a b c d e f g h i Bluestone JA, Herold K, Eisenbarth G (2010). "Genetics, pathogenesis and clinical interventions in type 1 diabetes". Nature. 464 (7293): 1293–1300. Bibcode:2010Natur.464.1293B. doi:10.1038/nature08933. PMID 20432533.
Jump up ^ "OMIM Entry – %222100 – DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM". Ncbi.nlm.nih.gov. Archived from the original on 8 August 2010. Retrieved 29 November 2011.
^ Jump up to: a b c Serena G, Camhi S, Sturgeon C, Yan S, Fasano A (2015). "The Role of Gluten in Celiac Disease and Type 1 Diabetes". Nutrients. 7 (9): 7143–62. doi:10.3390/nu7095329. PMC 4586524  . PMID 26343710.
Jump up ^ Bibbò, S; Dore, MP; Pes, GM; Delitala, G; Delitala, AP (February 2017). "Is there a role for gut microbiota in type 1 diabetes pathogenesis?". Annals of Medicine. 49 (1): 11–22. doi:10.1080/07853890.2016.1222449. PMID 27499366.
^ Jump up to: a b Rewers M, Ludvigsson J (2016). "Environmental risk factors for type 1 diabetes". The Lancet (Review). 387 (10035): 2340–8. doi:10.1016/S0140-6736(16)30507-4. PMID 27302273.
Jump up ^ Thayer KA, Heindel JJ, Bucher JR, Gallo MA (Jun 2012). "Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review". Environmental Health Perspectives (Review). 120 (6): 779–89. doi:10.1289/ehp.1104597. PMC 3385443  . PMID 22296744.
Jump up ^ "Pyriminil". Pyriminil. U.S. National Library of Medicine. Archived from the original on 4 July 2013.
Jump up ^ Wu J, Yan LJ (Apr 2015). "Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity". Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (Review). 8: 181–8. doi:10.2147/DMSO.S82272. PMC 4396517  . PMID 25897251.
Jump up ^ Brentjens R, Saltz L (2001). "Islet cell tumors of the pancreas: the medical oncologist's perspective". Surgical Clinics of North America (Review). 81 (3): 527–42. doi:10.1016/S0039-6109(05)70141-9. PMID 11459269.
Jump up ^ Chatzigeorgiou A, Harokopos V, Mylona-Karagianni C, Tsouvalas E, Aidinis V, Kamper EF (September 2010). "The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time". Annals of Medicine. 42 (6): 426–38. doi:10.3109/07853890.2010.495951. PMID 20568978.
^ Jump up to: a b Aly H, Gottlieb P (Aug 2009). "The honeymoon phase: intersection of metabolism and immunology". Current Opinion in Endocrinology, Diabetes and Obesity. 16 (4): 286–92. doi:10.1097/med.0b013e32832e0693. PMID 19506474.
Jump up ^ Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation (PDF). Geneva: World Health Organization. 2006. p. 21. ISBN 978-92-4-159493-6.
Jump up ^ Vijan, S (March 2010). "Type 2 diabetes". Annals of Internal Medicine. 152 (5): ITC31-15. doi:10.7326/0003-4819-152-5-201003020-01003. PMID 20194231.
Jump up ^ World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications" (PDF). Archived (PDF) from the original on 8 March 2003.
Jump up ^ ""Diabetes Care" January 2010". American Diabetes Association. Archived from the original on 13 January 2010. Retrieved 29 January 2010.
Jump up ^ Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL (August 2001). "Postchallenge hyperglycemia and mortality in a national sample of U.S. adults". Diabetes Care. 24 (8): 1397–402. doi:10.2337/diacare.24.8.1397. PMID 11473076.
^ Jump up to: a b "Diabetes". World Health Organization. Archived from the original on 26 January 2011. Retrieved 24 January 2011.
Jump up ^ "''Tolerx, Inc. and GlaxoSmithKline (GSK) Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint''". Biospace. Archived from the original on 29 September 2011. Retrieved 29 November 2011.
Jump up ^ "Macrogenics press release: ''MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint''". Macrogenics.com. 20 October 2010. Archived from the original on 22 January 2012. Retrieved 29 November 2011.
Jump up ^ Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J (November 1984). "Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis". The Lancet. 2 (8411): 1083–6. doi:10.1016/S0140-6736(84)91517-4. PMID 6150150.
Jump up ^ Shehadeh N, Shamir R, Berant M, Etzioni A (2001). "Insulin in human milk and the prevention of type 1 diabetes". Pediatric Diabetes. 2 (4): 175–7. doi:10.1034/j.1399-5448.2001.20406.x. PMID 15016183.
^ Jump up to: a b c Visser J, Rozing J, Sapone A, Lammers K, Fasano A (2009). "Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms". Annals of the New York Academy of Sciences. 1165: 195–205. doi:10.1111/j.1749-6632.2009.04037.x. PMC 2886850  . PMID 19538307.
Jump up ^ Virtanen SM, Knip M (December 2003). "Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age". The American Journal of Clinical Nutrition. 78 (6): 1053–67. PMID 14668264. Archived from the original on 19 July 2012.
Jump up ^ Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM (November 2001). "Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study". The Lancet. 358 (9292): 1500–3. doi:10.1016/S0140-6736(01)06580-1. PMID 11705562.
Jump up ^ Elliott RB, Pilcher CC, Fergusson DM, Stewart AW (1996). "A population based strategy to prevent insulin-dependent diabetes using nicotinamide". Journal of Pediatric Endocrinology and Metabolism. 9 (5): 501–9. doi:10.1515/JPEM.1996.9.5.501. PMID 8961125.
Jump up ^ Hogg-Kollars S; Al Dulaimi D; Tait K; Rostami K (2014). "Type 1 diabetes mellitus and gluten induced disorders". Gastroenterology and Hepatology from Bed to Bench (Review). 7 (4): 189–97. PMC 4185872  . PMID 25289132.
Jump up ^ "Your Diabetes Care Team". WebMD. Retrieved 1 November 2017.
Jump up ^ Feinman, RD; Pogozelski, WK; Astrup, A; Bernstein, RK; Fine, EJ; et al. (January 2015). "Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base". Nutrition. Burbank, Los Angeles County, Calif. 31 (1): 1–13. doi:10.1016/j.nut.2014.06.011. PMID 25287761.
Jump up ^ Ly, Trang T (2015). "Technology and type 1 diabetes: Closed-loop therapies". Current Pediatrics Reports. 3: 170–176. doi:10.1007/s40124-015-0083-y.
Jump up ^ "Stress". www.diabetes.org. American Diabetes Association. Archived from the original on 12 November 2014. Retrieved 11 November 2014.
Jump up ^ Shrivastava, Saurabh (5 March 2013). "Role of self-care in management of diabetes mellitus". Journal of Diabetes & Metabolic Disorders. 12: 14. doi:10.1186/2251-6581-12-14. Archived from the original on 12 April 2016.
Jump up ^ American Diabetes Association (2015). "DKA (ketoacidosis) and ketones". American Diabetes Association. Archived from the original on 29 April 2010.
Jump up ^ Tasker, Robert. C (2014). "Cerebral edema in children with diabetic ketoacidosis: vasogenic rather than cellular?". Pediatric Diabetes. 15: 261–270. doi:10.1111/pedi.12153. Archived from the original on 13 May 2016.
Jump up ^ American Diabetes Association Clinical Guidelines, 2010.
Jump up ^ Wright JR (2002). "From ugly fish to conquer death: J J R Macleod's fish insulin research, 1922–24". The Lancet. 359 (9313): 1238–42. doi:10.1016/S0140-6736(02)08222-3. PMID 11955558.
Jump up ^ https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia
Jump up ^ Blauw, H; Keith-Hynes, P; Koops, R; DeVries, JH (November 2016). "A Review of Safety and Design Requirements of the Artificial Pancreas". Annals of Biomedical Engineering. 44 (11): 3158–3172. doi:10.1007/s10439-016-1679-2. PMC 5093196  . PMID 27352278.
Jump up ^ Jennifer L. Larsen. "Pancreas Transplantation: Indications and Consequences". Edrv.endojournals.org. Archived from the original on 15 July 2012. Retrieved 29 November 2011.
^ Jump up to: a b c Bruni, A; Gala-Lopez, B; Pepper, AR; Abualhassan, NS; Shapiro, AJ (2014). "Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges". Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 7: 211–23. doi:10.2147/DMSO.S50789. PMC 4075233  . PMID 25018643.
Jump up ^ Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I (March 2006). "Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes". Diabetes. 55 (3): 774–9. doi:10.2337/diabetes.55.03.06.db05-1417. PMID 16505242.
Jump up ^ Granberg V, Ejskjaer N, Peakman M, Sundkvist G (2005). "Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy". Diabetes Care. 28 (8): 1959–64. doi:10.2337/diacare.28.8.1959. PMID 16043739.
Jump up ^ Huxley, Rachel R; Peters, Sanne A E; Mishra, Gita D; Woodward, Mark (February 2015). "Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis". The Lancet Diabetes & Endocrinology. 3: 198–206. doi:10.1016/S2213-8587(14)70248-7.
Jump up ^ Livingstone, SJ; Levin, D; Looker, HC; Lindsay, RS; Wild, SH; et al. (6 January 2015). "Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010". JAMA: The Journal of the American Medical Association. 313 (1): 37–44. doi:10.1001/jama.2014.16425. PMC 4426486  . PMID 25562264.
Jump up ^ Chen, Hsin-Chui; Su, Li-Ting; Linn, Shin-Zong; Sung, Fung-Chang; Ko, Ming-Chung; Li, Chung-Yi (January 2012). "Increased Risk of Urinary Tract Calculi Among Patients With Diabetes Mellitus–A Population-Based Cohort Study". Urology. 79 (1): 86–92. doi:10.1016/j.urology.2011.07.1431. PMID 22119251. Retrieved 28 November 2014.
Jump up ^ James, R; Hijaz, A (October 2014). "Lower urinary tract symptoms in women with diabetes mellitus: a current review". Current Urology Reports. 15 (10): 440. doi:10.1007/s11934-014-0440-3. PMID 25118849.
^ Jump up to: a b c McCoy, Krisha. "Sexual Issues and Type 1 Diabetes". everyday Health. Everyday Health Media, LLC. Archived from the original on 5 December 2014. Retrieved 28 November 2014.
^ Jump up to: a b c d e "Sexual Dysfunction in Women". Diabetes.co.uk. Diabetes Digital Media Ltd. Archived from the original on 9 November 2014. Retrieved 28 November 2014.
Jump up ^ Goswami, Sumanta; Vishwanath, Manikanta; Gangadarappa, Suma; Razdan, Rema; Inamdar, Mohammed (Jul–Sep 2014). "Efficacy of ellagic acid and sildenafil in diabetes-induced sexual dysfunction". Pharmacognosy Magazine. 10 (39): 581. doi:10.4103/0973-1296.139790. Retrieved 30 November 2014.
Jump up ^ Escobar-Morreale, Héctor F.; Roldán, Belén; Barrio, Raquel; Alonso, Milagros; Sancho, José; de la Calle, Hermenegildo; GarcÍa-Robles, Rafael (November 2000). "High Prevalence of the Polycystic Ovary Syndrome and Hirsutism in Women with Type 1 Diabetes Mellitus". The Journal of Clinical Endocrinology & Metabolism. 85 (11): 4182–4187. doi:10.1210/jcem.85.11.6931.
Jump up ^ Codner, Ethel; Escobar-Morreale, Héctor F. (April 2007). "Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus". The Journal of Clinical Endocrinology & Metabolism. 92 (4): 1209–1216. doi:10.1210/jc.2006-2641.
^ Jump up to: a b Aanstoot HJ, Anderson BJ, Daneman D, Danne T, Donaghue K, Kaufman F, Réa RR, Uchigata Y (October 2007). "The global burden of youth diabetes: perspectives and potential". Pediatric Diabetes. 8. Suppl 8 (s8): 1–44. doi:10.1111/j.1399-5448.2007.00326.x. PMID 17767619.
Jump up ^ Kasper, Dennis L; Braunwald, Eugene; Fauci, Anthony; et al. (2005). Harrison's Principles of Internal Medicine (16th ed.). New York: McGraw-Hill. ISBN 0-07-139140-1.
Jump up ^ Soltesz G, Patterson CC, Dahlquist G (October 2007). "Worldwide childhood type 1 diabetes incidence—what can we learn from epidemiology?". Pediatric Diabetes. 8. Suppl 6 (s6): 6–14. doi:10.1111/j.1399-5448.2007.00280.x. PMID 17727380.
^ Jump up to: a b "Fast Facts" (PDF). American Diabetes Association. Archived from the original (PDF) on 29 April 2015.
Jump up ^ Bottazzo, GF; Florin-Christensen, A; Doniach, D (30 November 1974). "Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies". The Lancet. 2 (7892): 1279–83. doi:10.1016/s0140-6736(74)90140-8. PMID 4139522.
Jump up ^ Herold, KC; Vignali, DA; Cooke, A; Bluestone, JA (April 2013). "Type 1 diabetes: translating mechanistic observations into effective clinical outcomes". Nature Reviews. Immunology. 13 (4): 243–56. doi:10.1038/nri3422. PMID 23524461.
Jump up ^ Shaw, Jonathan (2012). "diabetes: the silent pandemic and its impact on Australia" (PDF). Archived (PDF) from the original on 7 October 2016. Retrieved 19 October 2016.
Jump up ^ Australian Institute of Health and Welfare (2015). "Incidence of type 1 diabetes in Australia 2000–2013". Archived from the original on 7 October 2016. Retrieved 19 October 2016.
Jump up ^ Johnson, Linda (18 November 2008). "Study: Cost of diabetes $218B". USA Today. Associated Press. Archived from the original on 1 July 2012.
Jump up ^ Diabetes Research and Wellness Foundation Archived 11 May 2013 at the Wayback Machine.
^ Jump up to: a b Antvorskov, Julie C.; Josefsen, Knud; Engkilde, Kåre; Funda, David P.; Buschard, Karsten (2014-01-01). "Dietary gluten and the development of type 1 diabetes". Diabetologia (Review). 57 (9): 1770–1780. doi:10.1007/s00125-014-3265-1. ISSN 0012-186X. PMC 4119241  . PMID 24871322.
Jump up ^ Fairweather D, Rose NR (2002). "Type 1 diabetes: virus infection or autoimmune disease?". Nature Immunology. 3 (4): 338–40. doi:10.1038/ni0402-338. PMID 11919574.
Jump up ^ Petzold A; Solimena M; Knoch KP (2015). "Mechanisms of Beta Cell Dysfunction Associated With Viral Infection". Current Diabetes Reports (Review). 15 (10): 73. doi:10.1007/s11892-015-0654-x. PMC 4539350  . PMID 26280364. So far, none of the hypotheses accounting for virus-induced beta cell autoimmunity has been supported by stringent evidence in humans, and the involvement of several mechanisms rather than just one is also plausible.
Jump up ^ Butalia S, Kaplan GG, Khokhar B, Rabi DM (18 August 2016). "Environmental Risk Factors and Type 1 Diabetes: Past, Present, and Future". Canadian Journal of Diabetes (Review). 40: 586–593. doi:10.1016/j.jcjd.2016.05.002. PMID 27545597.
^ Jump up to: a b Minami, K; Seino, S (18 March 2013). "Current status of regeneration of pancreatic β-cells". Journal of Diabetes Investigation. 4 (2): 131–41. doi:10.1111/jdi.12062. PMC 4019265  . PMID 24843642.
Jump up ^ Pagliuca, FW; Millman, JR; Gürtler, M; Segel, M; Van Dervort, A; Ryu, JH; Peterson, QP; Greiner, D; Melton, DA (9 October 2014). "Generation of functional human pancreatic β cells in vitro". Cell. 159 (2): 428–39. doi:10.1016/j.cell.2014.09.040. PMC 4617632  . PMID 25303535.
Jump up ^ Rezania, A; Bruin, JE; Arora, P; Rubin, A; Batushansky, I; Asadi, A; O'Dwyer, S; Quiskamp, N; Mojibian, M; Albrecht, T; Yang, YH; Johnson, JD; Kieffer, TJ (November 2014). "Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells". Nature Biotechnology. 32 (11): 1121–33. doi:10.1038/nbt.3033. PMID 25211370.
^ Jump up to: a b c Lernmark A, Larsson HE (Feb 2013). "Immune therapy in type 1 diabetes mellitus". Nature Reviews Endocrinology. 9 (2): 92–103. doi:10.1038/nrendo.2012.237. PMID 23296174.
External links[edit]
Classification
V · T · D
ICD-10: E10
ICD-9-CM: 250.01
OMIM: 222100
MeSH: D003922
DiseasesDB: 3649
External resources
MedlinePlus: 000305
eMedicine: med/546
Diabetes mellitus type 1 at Curlie (based on DMOZ)
Kids and Teens: Type 1 Diabetes at Curlie (based on DMOZ)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – Diabetes in America Textbook (PDFs)
IDF Diabetes Atlas
type 1 Diabetes at the American Diabetes Association
Chamberlain, James J.; Kalyani, Rita Rastogi; Leal, Sandra; Rhinehart, Andrew S.; Shubrook, Jay H.; Skolnik, Neil; Herman, William H. (12 September 2017). "Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes". Annals of Internal Medicine. doi:10.7326/M17-1259.
[show]
v
t
e
Diseases of the endocrine system (E00–E35, 240–259)
Pancreas/
glucose
metabolism
Hypofunction
Diabetes mellitus
types:
type 1
type 2
gestational
MODY 1 2 3 4 5 6
complications
coma
angiopathy
ketoacidosis
nephropathy
neuropathy
retinopathy
cardiomyopathy
insulin receptor (Rabson–Mendenhall syndrome)
Insulin resistance
Hyperfunction
Hypoglycemia
beta cell (Hyperinsulinism)
G cell (Zollinger–Ellison syndrome)
Hypothalamic/
pituitary axes
Hypothalamus
gonadotropin
Kallmann syndrome
Adiposogenital dystrophy
CRH (Tertiary adrenal insufficiency)
vasopressin (Neurogenic diabetes insipidus)
general (Hypothalamic hamartoma)
Pituitary
Hyperpituitarism
anterior
Acromegaly
Hyperprolactinaemia
Pituitary ACTH hypersecretion
posterior (SIADH)
general (Nelson's syndrome)
Hypopituitarism
anterior
Kallmann syndrome
Growth hormone deficiency
Hypoprolactinemia
ACTH deficiency/Secondary adrenal insufficiency
GnRH insensitivity
FSH insensitivity
LH/hCG insensitivity
posterior (Neurogenic diabetes insipidus)
general
Empty sella syndrome
Pituitary apoplexy
Sheehan's syndrome
Lymphocytic hypophysitis
Thyroid
Hypothyroidism
Iodine deficiency
Cretinism
Congenital hypothyroidism
Myxedema
Euthyroid sick syndrome
Hyperthyroidism
Hyperthyroxinemia
Thyroid hormone resistance
Familial dysalbuminemic hyperthyroxinemia
Hashitoxicosis
Thyrotoxicosis factitia
Graves' disease
Thyroiditis
Acute infectious
Subacute
De Quervain's
Subacute lymphocytic
Autoimmune/chronic
Hashimoto's
Postpartum
Riedel's
Goitre
Endemic goitre
Toxic nodular goitre
Toxic multinodular goiter
Thyroid nodule
Parathyroid
Hypoparathyroidism
Pseudohypoparathyroidism
Pseudopseudohypoparathyroidism
Hyperparathyroidism
Primary
Secondary
Tertiary
Osteitis fibrosa cystica
Adrenal
Hyperfunction
aldosterone: Hyperaldosteronism/Primary aldosteronism
Conn syndrome
Bartter syndrome
Glucocorticoid remediable aldosteronism
AME
Liddle's syndrome
17α CAH
cortisol: Cushing's syndrome (Pseudo-Cushing's syndrome)
sex hormones: 21α CAH
11β CAH
Hypofunction/
Adrenal insufficiency
(Addison's, WF)
aldosterone: Hypoaldosteronism
21α CAH
11β CAH
cortisol: CAH
Lipoid
3β
11β
17α
21α
sex hormones: 17α CAH
Gonads
ovarian: Polycystic ovary syndrome
Premature ovarian failure
testicular: enzymatic
5α-reductase deficiency
17β-hydroxysteroid dehydrogenase deficiency
aromatase excess syndrome
Androgen receptor (Androgen insensitivity syndrome)
general: Hypogonadism (Delayed puberty)
Hypergonadism
Precocious puberty
Hypoandrogenism
Hypoestrogenism
Hyperandrogenism
Hyperestrogenism
Postorgasmic illness syndrome
Height
Dwarfism/Short stature
Midget
Laron syndrome
Psychosocial
Ateliosis
Gigantism
Multiple
Autoimmune polyendocrine syndrome multiple
APS1
APS2
Carcinoid syndrome
Multiple endocrine neoplasia
1
2A
2B
Progeria
Werner syndrome
Acrogeria
Metageria
Woodhouse–Sakati syndrome
[show]
v
t
e
Diabetes (E10–E14, 250)
Types
Type 1
Type 2
LADA
Gestational diabetes
Diabetes and pregnancy
Prediabetes
Impaired fasting glucose
Impaired glucose tolerance
Insulin resistance
KPD
MODY
Neonatal
Transient
Permanent
Type 3c (Pancreatogenic)
Blood tests
Blood sugar level
Glycosylated hemoglobin
Glucose tolerance test
Postprandial glucose test
Fructosamine
Glucose test
C-peptide
Noninvasive glucose monitor
Insulin tolerance test
Management
Diabetic diet
Anti-diabetic drugs
Insulin therapy
intensive
conventional
pulsatile
Cure
Embryonic stem cells
Artificial pancreas
Other
Gastric bypass surgery
Complications
Diabetic comas
Hypoglycemia
Ketoacidosis
Hyperosmolar hyperglycemic state
Diabetic foot
ulcer
Neuropathic arthropathy
Organs in diabetes
Blood vessels
Muscle
Kidney
Nerves
Retina
Heart
Diabetic skin disease
Diabetic dermopathy
Diabetic bulla
Diabetic cheiroarthropathy
Neuropathic ulcer
Hyperglycemia
Hypoglycemia
Other
Glossary of diabetes
Notable people with type 1 diabetes
[show]
v
t
e
Hypersensitivity and autoimmune diseases (279.5–6)
Type I/allergy/atopy
(IgE)
Foreign
Atopic eczema
Allergic urticaria
Allergic rhinitis (Hay fever)
Allergic asthma
Anaphylaxis
Food allergy
common allergies include: Milk
Egg
Peanut
Tree nut
Seafood
Soy
Wheat
Penicillin allergy
Autoimmune
Eosinophilic esophagitis
Type II/ADCC
IgM
IgG
Foreign
Hemolytic disease of the newborn
Autoimmune
Cytotoxic
Autoimmune hemolytic anemia
Immune thrombocytopenic purpura
Bullous pemphigoid
Pemphigus vulgaris
Rheumatic fever
Goodpasture's syndrome
Guillain–Barré syndrome
"Type V"/receptor
Graves' disease
Myasthenia gravis
Pernicious anemia
Type III
(Immune complex)
Foreign
Henoch–Schönlein purpura
Hypersensitivity vasculitis
Reactive arthritis
Farmer's lung
Post-streptococcal glomerulonephritis
Serum sickness
Arthus reaction
Autoimmune
Systemic lupus erythematosus
Subacute bacterial endocarditis
Rheumatoid arthritis
Type IV/cell-mediated
(T cells)
Foreign
Allergic contact dermatitis
Mantoux test
Autoimmune
Diabetes mellitus type 1
Hashimoto's thyroiditis
Multiple sclerosis
Coeliac disease
Giant-cell arteritis
Postorgasmic illness syndrome
Reactive arthritis
GVHD
Transfusion-associated graft versus host disease
Unknown/
multiple
Foreign
Hypersensitivity pneumonitis
Allergic bronchopulmonary aspergillosis
Transplant rejection
Latex allergy (I+IV)
Autoimmune
Sjögren's syndrome
Autoimmune hepatitis
Autoimmune polyendocrine syndrome
APS1
APS2
Autoimmune adrenalitis
Systemic autoimmune disease
Retrieved from "https://en.wikipedia.org/w/index.php?title=Diabetes_mellitus_type_1&oldid=818590232"
Categories:
Diabetes
Autoimmune diseases
Enterovirus-associated diseases
Hidden categories:
Webarchive template wayback links
Use dmy dates from June 2013
Infobox medical condition (new)
All articles with unsourced statements
Articles with unsourced statements from March 2017
Articles with unsourced statements from July 2013
Articles with DMOZ links
RTT
RTTNEURO
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
In other projects
Wikimedia Commons
Languages
العربية
Català
Deutsch
ދިވެހިބަސް
Eesti
Ελληνικά
Español
فارسی
Français
한국어
Հայերեն
हिन्दी
Bahasa Indonesia
Italiano
עברית
Kapampangan
မြန်မာဘာသာ
日本語
ଓଡ଼ିଆ
Polski
Português
Русский
Shqip
Simple English
Slovenščina
Svenska
Українська
中文
Edit links
This page was last edited on 4 January 2018, at 12:52.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

value: mw-page-base noprint

value: mw-head-base noprint

value: firstHeading firstHeading en

value: siteSub noprint

value: jump-to-nav mw-jump

tag: sup

value:
/wiki/Nonketotic_hyperosmolar_coma
mw-redirect
Nonketotic hyperosmolar coma

value:
/wiki/Celiac_disease
mw-redirect
Celiac disease

value:
/wiki/Diagnostic_method
mw-redirect
Diagnostic method

value:
/wiki/Blurry_vision
mw-redirect
Blurry vision

value:
/wiki/Insulin_therapy
mw-redirect
Insulin therapy

value:
/wiki/Chronic_renal_failure
mw-redirect
Chronic renal failure

value: <video id="mwe_player_1" poster="//upload.wikimedia.org/wikipedia/commons/thumb/8/85/Diabetes_video.webm/854px--Diabetes_video.webm.jpg" controls="" preload="none" autoplay="" style="width:854px;height:480px" class="kskin" data-durationhint="1055.407" data-startoffset="0" data-mwtitle="Diabetes_video.webm" data-mwprovider="wikimediacommons"><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/8/85/Diabetes_video.webm/Diabetes_video.webm.480p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="SD WebM (480P)" data-shorttitle="WebM 480P" data-transcodekey="480p.webm" data-width="854" data-height="480" data-bandwidth="569064" data-framerate="30"/><source src="//upload.wikimedia.org/wikipedia/commons/8/85/Diabetes_video.webm" type="video/webm; codecs="vp9, opus"" data-title="Original WebM file, 1,812 × 1,018 (927 kbps)" data-shorttitle="WebM source" data-width="1812" data-height="1018" data-bandwidth="927184" data-framerate="30"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/8/85/Diabetes_video.webm/Diabetes_video.webm.720p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="HD WebM (720P)" data-shorttitle="WebM 720P" data-transcodekey="720p.webm" data-width="1280" data-height="720" data-bandwidth="1143664" data-framerate="30"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/8/85/Diabetes_video.webm/Diabetes_video.webm.160p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="Low bandwidth WebM (160P)" data-shorttitle="WebM 160P" data-transcodekey="160p.webm" data-width="284" data-height="160" data-bandwidth="183376" data-framerate="30"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/8/85/Diabetes_video.webm/Diabetes_video.webm.240p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="Small WebM (240P)" data-shorttitle="WebM 240P" data-transcodekey="240p.webm" data-width="426" data-height="240" data-bandwidth="238792" data-framerate="30"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/8/85/Diabetes_video.webm/Diabetes_video.webm.360p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="WebM (360P)" data-shorttitle="WebM 360P" data-transcodekey="360p.webm" data-width="640" data-height="360" data-bandwidth="380960" data-framerate="30"/></video>

attr: alt src width height class srcset data-file-width data-file-height

value: The Environmental Determinants of Diabetes in the Young

value: Genetic causes of diabetes mellitus type 1

value:
/wiki/Identical_twin
mw-redirect
Identical twin

value:
/wiki/MHC_Class_II
mw-redirect
MHC Class II

value:
/wiki/Environmental_Protection_Agency
mw-redirect
Environmental Protection Agency

value:
/wiki/Islets_of_Langerhans
mw-redirect
Islets of Langerhans

value:
/wiki/Autoimmune_response
mw-redirect
Autoimmune response

value:
/wiki/Impaired_fasting_glycaemia
mw-redirect
Impaired fasting glycaemia

value: float: right; margin-left:15px; text-align:center

value:
/wiki/Plasma_glucose
mw-redirect
Plasma glucose

value: Diabetes control and complications trial

value:
/wiki/Fungal_infection_in_animals
mw-redirect
Fungal infection in animals

value: This claim needs references to reliable sources. (March 2017)

value:
noprint Inline-Template Template-Fact
white-space:nowrap;

value:
/wiki/Islet_cell_autoantibodies
mw-redirect
Islet cell autoantibodies

value:
/wiki/Insulin_autoantibodies
mw-redirect
Insulin autoantibodies

value:
/wiki/Atomic_mass_unit
mw-redirect
Atomic mass unit

value:
/wiki/Glutamic_acid_decarboxylase
mw-redirect
Glutamic acid decarboxylase

value:
/wiki/Latent_autoimmune_diabetes
mw-redirect
Latent autoimmune diabetes

value:
/wiki/Cyclosporine_A
mw-redirect
Cyclosporine A

value:
/wiki/Immunosuppressive_agent
mw-redirect
Immunosuppressive agent

value: This claim needs references to reliable sources. (July 2013)

value:
/wiki/Immunosuppressive_drugs
mw-redirect
Immunosuppressive drugs

value:
/wiki/Brittle_diabetes
mw-redirect
Brittle diabetes

value: Edit section: Islet cell transplantation

value:
/wiki/Polycystic_ovarian_syndrome
mw-redirect
Polycystic ovarian syndrome

value: List of people with diabetes mellitus type 1

value: Medical Research Council (United Kingdom)

value:
/wiki/Canadian_Diabetes_Association
mw-redirect
Canadian Diabetes Association

value:
/wiki/DNA_vaccine
mw-redirect
DNA vaccine

value:
nofollow
external text
http://www.diabetesbluecircle.org

value:
nofollow
external text
//doi.org/10.2337%2Fdc14-1140

value:
/wiki/PubMed_Identifier
mw-redirect
PubMed Identifier

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24935775

value:
nofollow
external text
//doi.org/10.1111%2Fapt.12973

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25270960

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16530579

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21293223

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23062861

value:
nofollow
external text
//doi.org/10.1038%2Fnrgastro.2015.156

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26392070

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16306330

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27302272

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26379145

value:
nofollow
external text
//doi.org/10.1038%2Fnature08933

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20432533

value:
nofollow
external text
//doi.org/10.3390%2Fnu7095329

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26343710

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27499366

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27302273

value:
nofollow
external text
//doi.org/10.1289%2Fehp.1104597

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22296744

value:
nofollow
external text
//doi.org/10.2147%2FDMSO.S82272

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25897251

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11459269

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20568978

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19506474

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20194231

value:
/wiki/World_Health_Organisation
mw-redirect
World Health Organisation

value:
nofollow
external text
//doi.org/10.2337%2Fdiacare.24.8.1397

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11473076

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6150150

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15016183

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19538307

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/14668264

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11705562

value:
nofollow
external text
//doi.org/10.1515%2FJPEM.1996.9.5.501

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8961125

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25289132

value:
nofollow
external text
//doi.org/10.1016%2Fj.nut.2014.06.011

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25287761

value:
nofollow
external text
//doi.org/10.1007%2Fs40124-015-0083-y

value:
nofollow
external text
//doi.org/10.1111%2Fpedi.12153

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11955558

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27352278

value:
nofollow
external text
//doi.org/10.2147%2FDMSO.S50789

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25018643

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16505242

value:
nofollow
external text
//doi.org/10.2337%2Fdiacare.28.8.1959

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16043739

value:
nofollow
external text
//doi.org/10.1001%2Fjama.2014.16425

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25562264

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22119251

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25118849

value:
nofollow
external text
//doi.org/10.1210%2Fjcem.85.11.6931

value:
nofollow
external text
//doi.org/10.1210%2Fjc.2006-2641

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17767619

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17727380

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/4139522

value:
nofollow
external text
//doi.org/10.1038%2Fnri3422

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23524461

value:
nofollow
external text
http://www.diabeteswellness.net

value:
nofollow
external text
//www.worldcat.org/issn/0012-186X

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24871322

value:
nofollow
external text
//doi.org/10.1038%2Fni0402-338

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11919574

value:
nofollow
external text
//doi.org/10.1007%2Fs11892-015-0654-x

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26280364

value:
nofollow
external text
//doi.org/10.1016%2Fj.jcjd.2016.05.002

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27545597

value:
nofollow
external text
//doi.org/10.1111%2Fjdi.12062

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24843642

value:
nofollow
external text
//doi.org/10.1016%2Fj.cell.2014.09.040

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25303535

value:
nofollow
external text
//doi.org/10.1038%2Fnbt.3033

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25211370

value:
nofollow
external text
//doi.org/10.1038%2Fnrendo.2012.237

value:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23296174

value: International Statistical Classification of Diseases and Related Health Problems

value:
nofollow
external text
https://omim.org/entry/222100

value: width:22em;width:100%; margin:0 0 0.5em 0;

value:
nofollow
http://www.diabetesatlas.org/
external text

value:
nofollow
external text
//doi.org/10.7326%2FM17-1259

value: ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases

value: List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders

value:
/wiki/Glucose_metabolism_disorder
mw-redirect
Glucose metabolism disorder

value:
/wiki/Neurogenic_diabetes_insipidus
mw-redirect
Neurogenic diabetes insipidus

value:
/wiki/Hypothalamic_hamartoma
mw-redirect
Hypothalamic hamartoma

value: Syndrome of inappropriate antidiuretic hormone

value:
/wiki/Luteinizing_hormone_insensitivity
mw-redirect
Luteinizing hormone insensitivity

value:
/wiki/Lymphocytic_hypophysitis
mw-redirect
Lymphocytic hypophysitis

value:
/wiki/Toxic_nodular_goitre
mw-redirect
Toxic nodular goitre

value:
/wiki/Toxic_multinodular_goiter
mw-redirect
Toxic multinodular goiter

value:
/wiki/Conn_syndrome
mw-redirect
Conn syndrome

value: Apparent mineralocorticoid excess syndrome

value: Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency

value:
/wiki/Sex_hormone
mw-redirect
Sex hormone

value: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

value: Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency

value:
/wiki/Waterhouse-Friderichsen_syndrome
mw-redirect
Waterhouse-Friderichsen syndrome

value: Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency

value:
/wiki/Gonadal_disorder
mw-redirect
Gonadal disorder

value:
/wiki/5%CE%B1-reductase_deficiency
mw-redirect
5α-reductase deficiency

value: Autoimmune polyendocrine syndrome multiple (page does not exist)

value: Autoimmune polyendocrine syndrome type 1

value: Autoimmune polyendocrine syndrome type 2

value: nowraplinks collapsible collapsed navbox-inner

value:
/wiki/Intensive_insulinotherapy
mw-redirect
Intensive insulinotherapy

value:
/wiki/Conventional_insulinotherapy
mw-redirect
Conventional insulinotherapy

value: nowraplinks collapsible autocollapse navbox-inner

value: Template:Hypersensitivity and autoimmune diseases

value: Template talk:Hypersensitivity and autoimmune diseases

value:
/wiki/Atopic_eczema
mw-redirect
Atopic eczema

value:
/wiki/Seafood_allergy
mw-redirect
Seafood allergy

value:
/wiki/Penicillin_drug_reaction
mw-redirect
Penicillin drug reaction

value:
/wiki/Goodpasture%27s_syndrome
mw-redirect
Goodpasture's syndrome

value:
/wiki/Pernicious_anemia
mw-redirect
Pernicious anemia

value: Transfusion-associated graft versus host disease

value:
/wiki/Sj%C3%B6gren%27s_syndrome
mw-redirect
Sjögren's syndrome

value: nowraplinks hlist collapsible autocollapse navbox-inner

value: Category:Webarchive template wayback links

value: Category:Infobox medical condition (new)

value: Category:All articles with unsourced statements

value: Category:Articles with unsourced statements from March 2017

value: Category:Articles with unsourced statements from July 2013

value: Discussion about edits from this IP address [ctrl-alt-n]

value: A list of edits made from this IP address [ctrl-alt-y]

value: You are encouraged to create an account and log in; however, it is not mandatory

value: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

value:
/wiki/Diabetes_mellitus_type_1
View the content page [ctrl-alt-c]
c

value: Discussion about the content page [ctrl-alt-t]

value: p-namespaces navigation vectorTabs p-namespaces-label

value:
p-variants
navigation
vectorMenu emptyPortlet
p-variants-label

value: Past revisions of this page [ctrl-alt-h]

value: p-views navigation vectorTabs p-views-label

value:
p-cactions
navigation
vectorMenu emptyPortlet
p-cactions-label

value:
mw-wiki-logo
/wiki/Main_Page
Visit the main page

value:
/wiki/Main_Page
Visit the main page [ctrl-alt-z]
z

value: Featured content – the best of Wikipedia

value: Find background information on current events

value:
/wiki/Special:Random
Load a random article [ctrl-alt-x]
x

value: portal navigation p-navigation p-navigation-label

value: Guidance on how to use and edit Wikipedia

value: About the project, what you can do, where to find things

value: A list of recent changes in the wiki [ctrl-alt-r]

value:
/wiki/Wikipedia:File_Upload_Wizard
Upload files [ctrl-alt-u]
u

value: A list of all special pages [ctrl-alt-q]

value: Permanent link to this revision of the page

value: Link to connected data repository item [ctrl-alt-g]

value: Printable version of this page [ctrl-alt-p]

value:
uls-settings-trigger
Language settings
0
button
true

value: سكري النوع الأول – Arabic

value: ހަކުރު ބަލީގެ ފުރަތަމަ ވައްތަރު – Divehi

value: Σακχαρώδης διαβήτης τύπου 1 – Greek

value: دیابت نوع ۱ – Persian

value: 1-ին տիպի շաքարային դիաբետ – Armenian

value: टाइप 1 डायबिटीज मेलेटस – Hindi

value: סוכרת מסוג 1 – Hebrew

value: ဆီးချိုအမျိုးအစား-၁ – Burmese

value: ମଧୁମେହ ଟାଇପ ୧ – Odia

value: Сахарный диабет 1-го типа – Russian

value: Цукровий діабет тип 1 – Ukrainian

value: /static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x

value: /static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x

value:
suggestions
display: none; font-size: 13px;

value: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Diabetes_mellitus_type_1 rootpage-Diabetes_mellitus_type_1 skin-vector action-view


text:
The Devil's Arithmetic
From Wikipedia, the free encyclopedia
Jump to: navigation, search
The Devil's Arithmetic is a historical fiction novel written by American author Jane Yolen and published in 1988. The book is about Hannah Stern, a Jewish girl who lives in New Rochelle, New York and is sent back in time to experience the Holocaust. During a Passover Seder, Hannah is transported back in time to 1942 Poland, during World War II, where she is sent to a death camp and learns the importance of knowing about the past.
The Devil's Arithmetic was nominated for the Nebula award for best novella in 1988[1] and won the National Jewish Book Award (in the category for children's literature) in 1989.[2] The script for a 1999 Showtime television film with the same title, starring Kirsten Dunst and Brittany Murphy, was also nominated for a Nebula Award.[3]
Plot[edit]
The book is a little different from the film. Hannah Stern is a 13-year-old Jewish girl living in the present day (time of publication: 1980s). She is bored by her relatives' stories about the past, is not looking forward to the Passover Seder, and is tired of her religion. When Hannah symbolically opens the door for the prophet Elijah, she is transported back in time to 1942 Poland, during World War II. At that time and place, the people believe she is Chaya Abramowicz, who is recovering from cholera, the fever that killed Chaya's parents a few months ago. The strange remarks Hannah/Chaya makes about the future and her inability to recognize her "aunt" Gitl and "uncle" Shmuel are blamed on the fever.
At her "uncle's" wedding, the Nazis come to transport the entire population of the village to a concentration camp near Donavin, and only Hannah knows all the terrors they will face: starvation, mistreatment, forced labor, and finally execution. She struggles to survive at the camp, with the help of a girl named Rivka. Uncle Shmuel and some other men try to escape; the men are caught. Fayge, who was going to be married to Shmuel, is killed because she runs to Shmuel when he is about to be shot with the men that were caught. Yitzchak escaped and lived in the forest with the partisans, fighting the Germans.
Later, when Hannah, Rivka, Esther, and Shifre are working, a guard overhears them talking instead of working. Shifre tries to reassure the guard they have been working, but he takes them anyway and leaves Hannah by herself. As the three are about to leave, Hannah takes Rivka's place by putting on her babushka. Since the guards don't know their faces, this goes unnoticed by the officer. The women are led to the gas chamber. She is then transported back to her family's Seder. Aunt Eva calls her over. Hannah looks at Aunt Eva's number; it is the same as Rivka's.
Hannah (when she was Chaya) was really the woman she was named after, Rivka was Aunt Eva, and Rivka's brother, Wolfe, was Grandpa Will. (Aunt Eva said that they changed their names when they got to America.)
The epilogue at the end of the novel reveals that when the camp was liberated, the survivors were Gitl (weighing a mere seventy-three pounds), Yitzchak, Rivka, and Leye (a worker in the camp) and her baby. Gitl and Yitzchak immigrate to Israel where Yitzchak becomes a politician while Gitl organizes a rescue mission that is dedicated to salvaging the lives of young survivors and locating family members. The organization is named after Chaya, her niece that died a hero.
References[edit]
Children and Young Adult Literature portal
Jump up ^ "(Awards & Nominations)". Jane Yolen. May 18, 2003. Retrieved April 29, 2012.
Jump up ^ National Jewish Book Award Winners
Jump up ^ "Year 2000 Nebula Nominations (Press Release)". SFWA (Science Fiction Writers of America). April 15, 2000. Retrieved February 21, 2011.
Retrieved from "https://en.wikipedia.org/w/index.php?title=The_Devil%27s_Arithmetic&oldid=803015596"
Categories:
1988 American novels
American historical novels
World War II novels
Holocaust literature
Novels set in New York City
Time travel novels
Novels set in Poland
Culture of New Rochelle, New York
American novels adapted into films
Hidden categories:
Use mdy dates from April 2012
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
Languages
Español
Edit links
This page was last edited on 29 September 2017, at 22:50.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

tag: div

attr: id class

value: mw-page-base noprint

key: html

type: local

value: mw-head-base noprint

tag: a

tag: i

attr: id class lang

value: firstHeading firstHeading en

value: siteSub noprint

value: jump-to-nav mw-jump

tag: b

attr: href title

attr: href class title

value: /wiki/Jewish mw-redirect Jewish

value:
/wiki/Death_camp
mw-redirect
Death camp

tag: p

value:
/wiki/Nebula_award_for_best_novella
mw-redirect
Nebula award for best novella

value: Portal:Children and Young Adult Literature

value: display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle

value: margin:0.5em 0 0.5em 1em;border:solid #aaa 1px

value:
nofollow
http://janeyolen.com/awards/
external text

value:
reflist mw-references-wrap
list-style-type: decimal;

value: Category:Culture of New Rochelle, New York

value: Category:American novels adapted into films

value: Discussion about edits from this IP address [ctrl-alt-n]

value: A list of edits made from this IP address [ctrl-alt-y]

value: You are encouraged to create an account and log in; however, it is not mandatory

value: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

value:
/wiki/The_Devil%27s_Arithmetic
View the content page [ctrl-alt-c]
c

value: Discussion about the content page [ctrl-alt-t]

value: p-namespaces navigation vectorTabs p-namespaces-label

value:
p-variants
navigation
vectorMenu emptyPortlet
p-variants-label

value: Past revisions of this page [ctrl-alt-h]

value: p-views navigation vectorTabs p-views-label

value:
p-cactions
navigation
vectorMenu emptyPortlet
p-cactions-label

value:
mw-wiki-logo
/wiki/Main_Page
Visit the main page

value:
/wiki/Main_Page
Visit the main page [ctrl-alt-z]
z

value: Featured content – the best of Wikipedia

value: Find background information on current events

value: portal navigation p-interaction p-interaction-label

value: List of all English Wikipedia pages containing links to this page [ctrl-alt-j]

value: Recent changes in pages linked from this page [ctrl-alt-k]

value: La aritmética del diablo (novela) – Spanish

value: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-The_Devil_s_Arithmetic rootpage-The_Devil_s_Arithmetic vector-experimental-print-styles vector-nav-directionality skin-vector action-view